Live Breaking News & Updates on Oncology At Allegheny Health Network Cancer Institute

Stay updated with breaking news from Oncology at allegheny health network cancer institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer

Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, and Allegheny Health Network, an academic healthcare system serving the diverse greater western Pennsylvania community that provides pioneering medical research and education programs focused on transforming healthcare, today announced the initiation of a Phase 1/2 study to assess the safety and efficacy of azeliragon in patients refractory to first-line treatment of metastatic pancreatic cancer. ....

United States , Stepheng Marcus , Nathan Bahary , Tv Therapeutics Inc , Eastern Cooperative Oncology Group , Cantex Pharmaceuticals Inc , Oncology At Allegheny Health Network Cancer Institute , National Cancer Institute , Ecog Gi Steering Committee , Allegheny Health Network , Pancreatic Task , Cantex Pharmaceuticals , Chief Executive , Academic Chief , Medical Oncology , Allegheny Health Network Cancer , Pancreatic Task Force , Cooperative Oncology Group , Press Release ,